Financials

	2013	2014
Net sales	0.24 0.22 0.2 0.18 0.34 23.19 0.35 2.42 0.96 12.15 0.92 0.9 38.3	3.68 3.28 3.03 2.75 5.14 349.1 5.23 36.51 14.45 182.91 13.8 13.51 576.65
Net income	-653K -584K -539K -489K -914K -62.03M -929K -6.49M -2.57M -32.5M -2.45M -2.4M -102M	-1.31M -1.17M -1.08M -981K -1.84M -125M -1.87M -13.03M -5.16M -65.26M -4.92M -4.82M -206M
Net Debt	1.33M 1.18M 1.09M 992K 1.86M 126M 1.89M 13.17M 5.21M 65.99M 4.98M 4.87M 208M	1.89M 1.69M 1.56M 1.42M 2.65M 180M 2.69M 18.81M 7.45M 94.24M 7.11M 6.96M 297M

* Estimated data More financial data

Company Profile

Oncologix Tech, Inc. is a shell company. The Company is a non-operating holding Company. The Company has no operations. The Company seeks to acquire an operating company via reverse merger.

Employees

191

Sector

Investment Holding Companies

More about the company

Quotes

Date	Price	Change	Volume

Delayed Quote OTC Markets

More quotes

Market Closed - OTC Markets 10:57:17 2026-10-16 EDT			5-day change	1st Jan Change
0.000001 ^USD	-99.00%		0.00%	-99.00%

24-11-28	Reliance's US unit buys $12 million stake in helium explorer Wavetech Helium	RE
22-05-01	DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction.	CI

Market Cap	306K 273K 253K 229K 428K 29.06M 435K 3.04M 1.2M 15.23M 1.15M 1.12M 48M	P/E 2013	-1.03x	P/E 2014	-0.47x
Enterprise Value	2.2M 1.97M 1.82M 1.65M 3.08M 209M 3.13M 21.85M 8.65M 109M 8.26M 8.08M 345M	EV / Sales 2013	8,716,069x	EV / Sales 2014	721,342x
Free-Float	99%	Yield 2013 *	-	Yield 2014	-

24-11-28	Reliance's US unit buys $12 million stake in helium explorer Wavetech Helium	RE
22-05-01	DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction.	CI
16-12-02	Oncologix Tech, Inc. Announces Management Changes	CI
16-08-30	Oncologix Tech, Inc. announced that it expects to receive $10 million in funding from Diversified Innovative Marketing Enterprises Limited	CI
16-06-24	Oncologix Tech, Inc. Announces Board Changes	CI
15-07-29	Oncologix Tech, Inc. Appoints Nikole Jessie as Director of Marketing and Public Relations	CI
15-07-21	Oncologix Tech Inc. Reports Revenue Results Third Quarter and Nine Months Ending May 31, 2015	CI
15-07-21	Oncologix Tech Eyes Acquisitions	CI
15-04-14	Oncologix Tech, Inc. Announces Earnings Results for the Second Quarter and Revenue Results for the Six Months Ended February 28, 2015; Provides Earnings Guidance for the Third Quarter and Full Year of Fiscal 2015	CI
15-04-14	Oncologix Seeks Acquisitions	CI
15-01-16	Oncologix Tech, Inc. Reports Earnings Results for the First Quarter Ending November 30, 2014; Provides Earnings Guidance for Second Quarter of 2015	CI
14-12-30	OCLG Mulls Acquisitions	CI
14-10-07	Oncologix Tech Mulls Acquisitions	CI

22-05-02	DNAGO and Oncologix Tech, Inc. Announce Agreement for Business Combination to Create Publicly Listed Company Focused on Providing clinical genetic testing on all 20,000+ genes encompassing 7,000+ rare genetic diseases at affordable price	GL
22-05-02	DNAGO and Oncologix Tech, Inc. Announce Agreement for Business Combination to Create Publicly Listed Company Focused on Providing clinical genetic testing on all 20,000+ genes encompassing 7,000+ rare genetic diseases at affordable price	AQ

Oncologix Tech, Inc. Stock

Stocks

OCLG

US68230M2098

Investment Holding Companies

Valuation: Oncologix Tech, Inc.

Chart: Oncologix Tech, Inc.

Latest news: Oncologix Tech, Inc.

Press Releases: Oncologix Tech, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Oncologix Tech, Inc.

Shell Companies

Financials

Company Profile

Quotes

1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		0.02
10 years	0		0.02

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ONCOLOGIX TECH, INC.	-99.00%	0.00%	-	-	1.66K
INVESTOR AB	+0.74%	-1.81%	+28.90%	+103.97%	126B
INDUSTRIVÄRDEN AB	+0.20%	-2.41%	+26.88%	+79.32%	21.93B
HAL TRUST	+2.33%	+1.95%	+20.66%	+57.84%	16.89B
MERITZ FINANCIAL GROUP INC.	-2.14%	-1.54%	+12.40%	+161.89%	15.52B
LUNDBERG B	+0.09%	-1.23%	+9.30%	+26.26%	14.09B
INVESTMENT AB LATOUR	+0.10%	+0.19%	-15.32%	+11.72%	13.38B
BAJAJ HOLDINGS & INVESTMENT LIMITED	-0.63%	+0.97%	-14.97%	+57.59%	13.1B
WASHINGTON H. SOUL PATTINSON AND COMPANY LIMITED	+0.50%	+0.02%	+23.10%	+35.60%	12.33B
KINGDOM HOLDING COMPANY	-6.17%	-14.22%	+46.72%	+64.27%	12B
Average	-10.40%	-1.33%	+15.30%	+66.49%	24.57B
Weighted average by Cap.	+0.12%	-1.59%	+21.82%	+84.93%